Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GreenLight Biosciences Holdings, PBC - Common Stock (NQ: GRNA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.2994 (1,015)
Ask (Size) 0.3050 (9)
Prev. Close 0.2995
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
From GreenLight Biosciences
Via GlobeNewswire
GREENLIGHT BIOSCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of GreenLight Biosciences Holdings, PBC - GRNA
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023
Via Benzinga
Recap: GreenLight Biosciences Q1 Earnings
Via Benzinga
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
From GreenLight Biosciences
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Greenlight Biosciences Stock Was in the Red Today
Via The Motley Fool
Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
GRNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of GreenLight Biosciences Holdings, PBC Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences Releases Inaugural Sustainability Report
From GreenLight Biosciences
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences to Host R&D Day Series on Plant and Human Health Development Strategy
From GreenLight Biosciences
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
From GreenLight Biosciences
Via GlobeNewswire
GreenLight Biosciences and Epivax Therapeutics Sign Exclusive Collaboration Agreement to Develop Personalized Cancer Vaccines
From GreenLight Biosciences
Via GlobeNewswire
Why Tesla Shares Are Trading Lower; Here Are 32 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.